Mark McLean

460 total citations
19 papers, 337 citations indexed

About

Mark McLean is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mark McLean has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Mark McLean's work include Opioid Use Disorder Treatment (10 papers), HIV/AIDS Research and Interventions (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Mark McLean is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), HIV/AIDS Research and Interventions (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Mark McLean collaborates with scholars based in Canada, Australia and Ireland. Mark McLean's co-authors include Annabel Mead, Seonaid Nolan, Keith Ahamad, Evan Wood, Jesse D. Raffa, Milan Khara, Jason Grebely, Ján Klimas, Mark Viljoen and Fiona Duncan and has published in prestigious journals such as JAMA, Addiction and Drug and Alcohol Dependence.

In The Last Decade

Mark McLean

19 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark McLean Canada	10	172	140	73	68	52	19	337
Stephan Walcher Germany	10	214 1.2×	197 1.4×	15 0.2×	102 1.5×	36 0.7×	15	396
Joseph H. Donroe United States	9	120 0.7×	177 1.3×	20 0.3×	5 0.1×	12 0.2×	19	298
Sarah Welch United States	8	203 1.2×	181 1.3×	19 0.3×	6 0.1×	26 0.5×	19	385
Scott Fletcher United States	7	100 0.6×	126 0.9×	8 0.1×	15 0.2×	18 0.3×	15	268
Furaha Kariburyo United States	8	132 0.8×	267 1.9×	6 0.1×	19 0.3×	17 0.3×	14	478
Elise Bailey United States	6	118 0.7×	254 1.8×	5 0.1×	35 0.5×	7 0.1×	7	433
David B. Liss United States	10	142 0.8×	167 1.2×	5 0.1×	6 0.1×	51 1.0×	20	305
Jeffrey P. Hau Canada	8	56 0.3×	120 0.9×	4 0.1×	11 0.2×	15 0.3×	16	243
Jeffrey McPheeters United States	8	443 2.6×	556 4.0×	3 0.0×	24 0.4×	23 0.4×	21	700
Asma Sriha Belguith Tunisia	8	62 0.4×	19 0.1×	7 0.1×	24 0.4×	34 0.7×	33	227

Countries citing papers authored by Mark McLean

Since Specialization

Citations

This map shows the geographic impact of Mark McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McLean more than expected).

Fields of papers citing papers by Mark McLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McLean. The network helps show where Mark McLean may publish in the future.

Co-authorship network of co-authors of Mark McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McLean. A scholar is included among the top collaborators of Mark McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McLean. Mark McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Klaire, Sukhpreet, et al.. (2023). Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study. Journal of Addiction Medicine. 17(6). 711–713. 12 indexed citations

Nolan, Seonaid, et al.. (2022). A Hospital-based Managed Alcohol Program in a Canadian Setting. Journal of Addiction Medicine. 17(2). 190–196. 4 indexed citations

McLean, Mark, et al.. (2021). Case report: rapid inpatient methadone titration during pregnancy. Journal of Substance Use. 27(4). 418–421. 5 indexed citations

Ti, Lianping, Nadia Fairbairn, Keith Ahamad, et al.. (2020). Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction. 116(7). 1892–1900. 18 indexed citations

Danilewitz, Marlon & Mark McLean. (2019). High‐dose buprenorphine for treatment of high potency opioid use disorder. Drug and Alcohol Review. 39(2). 135–137. 19 indexed citations

Ahamad, Keith, et al.. (2019). Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report. Journal of Addiction Medicine. 13(5). 415–417. 6 indexed citations

McLean, Mark. (2019). Essential Leadership Competencies for College Presidents in a Metrics-Driven Community College System. Aquila Digital Community (University of Southern Mississippi). 1 indexed citations

Gorfinkel, Lauren, Ján Klimas, Huiru Dong, et al.. (2019). In-Hospital Training in Addiction Medicine: A Mixed-Methods Study of Health Care Provider Benefits and Differences. Substance Abuse. 40(2). 207–213. 17 indexed citations

Wood, Evan, Loai Albarqouni, Carolyn J. Green, et al.. (2018). Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?. JAMA. 320(8). 825–825. 70 indexed citations

10.

Cortina, Sandra, et al.. (2017). Case Report: High-Dose Methadone Transition to Buprenorphine/Naloxone in an Inpatient with a Prolonged QT Interval. The Canadian Journal of Addiction. 8(1). 25–28. 21 indexed citations

11.

Klimas, Ján, Keith Ahamad, Mark McLean, et al.. (2017). Impact of a Brief Addiction Medicine Training Experience on Knowledge Self-Assessment among Medical Learners. Substance Abuse. 38(2). 141–144. 21 indexed citations

12.

Buxton, Jane A., Scott Harrison, Keith Ahamad, et al.. (2016). Implementation of a Naloxone Distribution Program in an Inpatient Addiction Service: A Case Study. The Canadian Journal of Addiction. 7(1). 22–25. 1 indexed citations

13.

Raffa, Jesse D., Jason Grebely, Mark Viljoen, et al.. (2008). Primary drug resistance in antiretroviral-naïve injection drug users. International Journal of Infectious Diseases. 13(5). 577–583. 7 indexed citations

14.

Raffa, Jesse D., Jason Grebely, Mark Viljoen, et al.. (2007). Methadone Dosing Strategies in HIV-Infected Injection Drug Users Enrolled in a Directly Observed Therapy Program. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(3). 324–327. 11 indexed citations

15.

Grebely, Jason, Jesse D. Raffa, Fiona Duncan, et al.. (2007). Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users. Journal of Gastroenterology and Hepatology. 22(9). 1519–1525. 65 indexed citations

16.

Raffa, Jesse D., Jason Grebely, Tiffany Wong, et al.. (2007). The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug and Alcohol Dependence. 89(2-3). 306–309. 53 indexed citations

17.

Raffa, Jesse D., Jason Grebely, Mark Viljoen, et al.. (2007). Clinical Implications of Mutations at Reverse Transcriptase Codon 135 on Response to NNRTI-Based Therapy. PubMed Central. 1(1). 8–13. 2 indexed citations

18.

McLean, Mark, et al.. (2004). Drug overdose: prevention and response. Guidance for helplines.. 2 indexed citations

19.

McLean, Mark. (2003). Temporal Correlation Between Opiate Seizures in East/Southeast Asia and B.C. Heroin Deaths. Canadian Journal of Public Health. 94(5). 346–350. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact